December 1, 2017 Regulatory InDex Pharmaceuticals rapporterar nya data om cobitolimods verkningsmekanism Read more
December 1, 2017 Regulatory InDex Pharmaceuticals reports new mechanism of action data for cobitolimod Read more
November 21, 2017 Non Regulatory InDex Pharmaceuticals presenterar på Redeye Life Science Seminar 24 november 2017 Read more
November 17, 2017 Regulatory InDex Pharmaceuticals Holding AB (publ) delårsrapport för januari – september 2017 Read more
November 17, 2017 Regulatory InDex Pharmaceuticals Holding AB (publ) interim report January – September 2017 Read more
November 16, 2017 Non Regulatory InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee and financial reporting dates for 2018 Read more
November 16, 2017 Non Regulatory InDex Pharmaceuticals Holding AB (publ) offentliggör valberedning och datum för finansiell rapportering 2018 Read more
October 26, 2017 Non Regulatory InDex Pharmaceuticals will participate in the United European Gastroenterology Week (UEGW) Read more
October 26, 2017 Non Regulatory InDex Pharmaceuticals deltar på United European Gastroenterology Week (UEGW) Read more
August 25, 2017 Regulatory InDex Pharmaceuticals Holding AB (publ) delårsrapport för januari – juni 2017 Read more
August 25, 2017 Regulatory InDex Pharmaceuticals Holding AB (publ) interim report January – June 2017 Read more
August 9, 2017 Non Regulatory InDex Pharmaceuticals receives orphan-drug designation for pediatric ulcerative colitis in the US Read more
August 9, 2017 Non Regulatory InDex Pharmaceuticals får särläkemedelsstatus för pediatrisk ulcerös kolit beviljad i USA Read more
June 21, 2017 Regulatory InDex Pharmaceuticals enrolls first patient in the phase IIb study CONDUCT with cobitolimod Read more
June 21, 2017 Regulatory InDex Pharmaceuticals inkluderar första patienten i fas IIb-studien CONDUCT med cobitolimod Read more
May 30, 2017 Regulatory Bulletin from Annual General Meeting in InDex Pharmaceuticals Holding AB (publ) Read more